Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
276.00    11.00 (4.15%)
Bid:
268.00
Ask:
272.00
Spread: 4.00 (1.493%)
Market Cap: £247.17m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Pre-close Trading Update

15 Jul 2010 07:00

RNS Number : 3703P
Wilmington Group Plc
15 July 2010
 



 

 

15 July 2010

 

Wilmington Group plc

 

Pre Close Period Statement

 

Wilmington Group plc ('Wilmington' or 'the Group') today announces its pre close trading update.

Trading Performance

Trading performance for the year to 30 June 2010 is expected to be in line with the Board's expectations.

The Group's Publishing and Information business, which has generally performed well during the economic downturn, has seen overall trends in revenue and profit in the six months to 30 June 2010 in line with those experienced in the six months to 31 December 2009.

The Group's Training and Events business is expected to show revenues for the six months to 30 June 2010 marginally ahead of the corresponding period in the prior year. The legal training market has stabilised with the volume of face-to-face bookings in the quarter to June ahead of the corresponding period in the prior year. Webinar bookings continued to show good year-on-year growth. Trading in the investment banking sector continues to improve.

We continue to benefit from a strong balance sheet, low gearing and excellent cash flow and have significant unutilised committed bank facilities.

Outlook

The Group has produced a robust trading performance as a result of the prompt action taken to reduce costs in the prior financial year. The benefits of operational efficiencies and cost savings have come through as anticipated. Whilst trading conditions continue to be difficult our trading performance and the levels of bookings indicate that our principal markets have either stabilised or are showing signs of growth. The prevailing uncertainty surrounding the precise extent of Government spending cuts continues to cause some concern in those markets with exposure to the UK public sector.

Change, particularly new legislation or regulation, usually drives information and training requirements in the professional business markets we serve. The Board continues to believe that the professional markets will provide a good environment for medium term growth. To that end, we announced in May that we expect to invest up to £2 million over the course of the year in a number of organic product developments particularly in relation to the Flexible Legal Practice course, the overseas expansion of our business in the banking and finance sector and deeper content and enhanced functionality for a number of our information products.

-ends-

For further information, please contact:

Wilmington Group Plc

020 7422 6800

Charles Brady, Chief Executive

Basil Brookes, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne or Clare Thomas

Numis Securities

0207 260 1309

James Serjeant

RBS Hoare Govett

0207 678 8000

Sara Hale

 

 

Notes to Editors

Wilmington Group plc is one of the UK's leading providers of information and training for professional business markets. The Group provides training, arranges industry events and publishes directories, databases, magazines and special reports for a variety of markets including the legal, health, accounting, pension, charities and financial sectors. Capitalised at approximately £114 million, Wilmington floated on the London Stock Exchange in 1995.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLRDEISLII
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.